Patents Assigned to Immunetech Pharmaceuticals
  • Methods and compositions for the treatment of inflammatory bowel diseases and conditions
    Patent number: 5110795
    Abstract: Methods and compositions for the treatment of inflammatory bowel diseases, chemically-induced irritation and inflammation, and other irritative or inflammatory conditions utilizing the peptide sequences Asp-Ser-Asp-Pro-Arg, Asp-Ser-Asn-Pro-Arg, or derivatives or salts thereof are disclosed.
    Type: Grant
    Filed: January 26, 1990
    Date of Patent: May 5, 1992
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Methods and compositions for the treatment of non-IgE-mediated diseases
    Patent number: 5061692
    Abstract: Methods and compositions for the treatment of non-IgE-mediated inflammatory disease conditions utilizing the peptide Asp-Ser-Asp-Pro-Arg, or derivative thereof are disclosed.
    Type: Grant
    Filed: November 23, 1989
    Date of Patent: October 29, 1991
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Immunotherapeutic anti-inflammatory peptide agents
    Patent number: 4816449
    Abstract: Anti-inflammatory peptides of the formula A-B-C-D-E, useful in treating allergies, autoimmune diseases, and other disorders, and methods for using them are described.
    Type: Grant
    Filed: December 9, 1986
    Date of Patent: March 28, 1989
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Method of blocking immune complex binding to immunoglobulin Fc receptors
    Patent number: 4753927
    Abstract: A method of modulating immune responses in mammals by blocking immune complex binding to immunoglobulin Fc receptors is described, comprising administering a peptide comprising a portion selected from the amino acid sequence-Pro-Asp-Ala-Arg-His-Ser-Thr-Thr-Gln-Pro-Arg-Specific uses in reducing immune complex mediated inflammation or tissue destruction and in reducing the human allergic response are disclosed.
    Type: Grant
    Filed: January 21, 1986
    Date of Patent: June 28, 1988
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Method of blocking immune complex binding to immunoglobulin FC receptors
    Patent number: 4752601
    Abstract: A method of modulating immune complex mediated immune responses in mammals is described, comprising administering a peptide comprising the amino acid sequence-Thr-Ile-Ser-Lys-Ala-Lys-Gly-Gln-Pro-Arg-Specific uses in reducing immune complex mediated inflammation or tissue destruction and in modulating the proliferation or function of mononuclear cells are disclosed.
    Type: Grant
    Filed: April 1, 1986
    Date of Patent: June 21, 1988
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Peptide antagonists for the C5a anaphylatoxin
    Patent number: 4692511
    Abstract: Peptides and peptide compositions are disclosed which act as competitive antagonists for the C5a receptor and thus block inflammatory and immunomodulatory activity mediated by endogenous C5a.
    Type: Grant
    Filed: July 3, 1984
    Date of Patent: September 8, 1987
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Immunotherapeutic antiallergic polypeptide agents which bind to basophil immunoglobin Fc receptors
    Patent number: 4628045
    Abstract: A peptide having the amino acid sequence Asp-Ser-Glu-Pro-Arg and capable of blocking immune complex binding to immunoglobulin Fc receptors is disclosed.
    Type: Grant
    Filed: February 3, 1986
    Date of Patent: December 9, 1986
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn
  • Method of blocking immune complex binding to immunoglobulin Fc receptors
    Patent number: 4579840
    Abstract: Methods and peptides for blocking immunogloblin Fc receptors are set forth.
    Type: Grant
    Filed: August 12, 1983
    Date of Patent: April 1, 1986
    Assignee: Immunetech Pharmaceuticals
    Inventor: Gary S. Hahn